Phase II study of dose‐adjusted gemcitabine, dexamethasone, cisplatin, and rituximab in elderly relapsed diffuse large B‐cell lymphoma patients

High‐dose chemotherapy and autologous stem cell transplantation (ASCT) are too toxic for elderly patients with relapsed or refractory diffuse large B‐cell lymphoma (DLBCL). Therefore, effective and tolerable regimens for elderly patients are urgently needed. The present phase II study assessed the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamasaki, Satoshi, Kada, Akiko, Choi, Ilseung, Iida, Hiroatsu, Sekiguchi, Naohiro, Harada, Naoko, Sawamura, Morio, Shimomura, Takeshi, Komeno, Takuya, Yano, Takahiro, Yoshida, Isao, Yoshida, Shinichiro, Sunami, Kazutaka, Hishita, Terutoshi, Takatsuki, Hiroshi, Ohshima, Koichi, Takeshita, Morishige, Saito, Akiko M., Iwasaki, Hiromi, Nagai, Hirokazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Haematologic Malignancy ‐ Lymphoid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176064/
https://www.ncbi.nlm.nih.gov/pubmed/35844987
http://dx.doi.org/10.1002/jha2.111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176064/
https://www.ncbi.nlm.nih.gov/pubmed/35844987
http://dx.doi.org/10.1002/jha2.111

Ejemplares similares